| |
|
|
|
Neos Therapeutics Inc.  
|
|
0.5303 -0.033 (-0.06%) |
09-30 16:00 |
|
Open: |
0.57 |
Pre close: |
0.5629 |
Target:
|
0.79 
|
|
High: |
0.5854 |
Low: |
0.5303 |
Resistance:
|
0.67
0.75
|
|
Volume: |
333,092 |
Market Cap: |
28M |
Support:
|
0.55
0.46
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.57
|
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
0.65 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.71 |
Stochastic Oscillator |
%K(14,3):
|
4.16  |
|
MA(250): |
1.09 |
%D(3): |
1.90 |
|
Average Volume(K) |
3-Month: |
16960
|
52-Week |
High:
|
1.98 |
|
10-Days: |
23559 |
Low: |
0.55 |
|
RSI |
RSI(14):
|
29.38 |
Change(%): |
-61.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.382 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
49.76 |
|
EPS Est. Current Year |
-3.110 |
Return on Assets (ttm) |
-8.1 |
Shares Float (M) |
40.17 |
|
EPS Est. Next Year |
-1.440 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.83 |
|
EPS Est. Next Quarter |
-0.670 |
Qtrly Rev. Growth |
-16.0 |
% Held by Institutions |
42.90 |
|
Forward EPS |
-0.340 |
Gross Profit (p.s.) |
0.794 |
Shares Short (K) |
2260 |
|
Book Value (p.s.) |
-0.320 |
EBITDA (p.s.) |
-0.126 |
P/E |
-1.48 |
|
Sales Per Share |
1.246 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.77 |
|
Profit Margin |
-30.64 |
Operating Cash Flow
(M) |
-8.45 |
P/S |
0.45 |
|
Operating Margin |
-15.83 |
Levered Free Cash Flow
(M) |
-2.12 |
P/CF |
-3.33 |
|
|
|
|
|
|
